Krilogy Financial’s Lexaria Bioscience LEXX Stock Holding History

Krilogy Financial’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-1,610	Closed	-$13.5K	–	1142
2026 Q2	$13.5K	Buy	1,610 +300	+23%	+$3.25K	﹤0.01%	1062
2026 Q1	$19.4K	Hold	1,310	–	–	﹤0.01%	969
2025 Q4	$16K	Hold	1,310	–	–	﹤0.01%	919
2025 Q3	$21.2K	Buy	+1,310	New	+$19K	﹤0.01%	861

Krilogy Financial's LEXX Position: Q3 2026 in Review

Krilogy Financial sold out of Lexaria Bioscience (LEXX) in Q3 2026, closing a stake of 1,610 shares — an estimated $13.5K sold.

Krilogy Financial first reported a position in LEXX in Q3 2025 and held it in 4 quarters. The position peaked at $21.2K in Q3 2025. 0 funds tracked by Wall St. Rank hold LEXX as of Q3 2026.

Krilogy Financial reported no remaining Lexaria Bioscience position as of Q3 2026 after selling out during the quarter.
Krilogy Financial sold 1,610 Lexaria Bioscience shares in Q3 2026, an estimated $13.5K.
Krilogy Financial first reported a position in Lexaria Bioscience in Q3 2025 and held it in 4 quarters.
Krilogy Financial's Lexaria Bioscience position peaked at $21.2K in Q3 2025.
0 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.